Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gait Posture ; 31(2): 164-8, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19854655

ABSTRACT

Stair climbing can be measured using body-fixed sensors, whereby the origin and axes of the coordinate system are fixed with respect to the geometry of a body segment. These sensors can be part of a portable system, which provides the possibility to collect data in complex real-life environments. However due to the fact that the sensors are body-fixed, difficulties in determining the ground-based parameters of stair ascent can occur. The purpose of this study is to present a new approach for determining initial contacts based on a multi-chain biomechanical model combined with a new analysis method, in which relative hip height is compared to hip height during normal standing. Initial contacts obtained from the proposed method were compared to those obtained using an optical tracking device. An average absolute timing difference ranging from 0.04 (SD + or - 0.03) to 0.06 (+ or - 0.03) s and a root mean square error ranging from 0.05 to 0.07 s were found between the two techniques. This shows that the new approach presented in this study can be used to accurately determine initial contacts during stair ascent using portable equipment.


Subject(s)
Hip Joint/physiology , Locomotion/physiology , Posture/physiology , Adult , Algorithms , Biomechanical Phenomena , Female , Humans , Knee Joint/physiology , Male , Range of Motion, Articular/physiology , Statistics, Nonparametric
2.
Auton Autacoid Pharmacol ; 26(2): 169-81, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16553645

ABSTRACT

The involvement of Ca(2+) sensitization mediated through Rho kinase in the contractility of rat epididymal vas deferens was investigated using Rho kinase inhibitors, trans-4-[(1R)-1-aminoethyl]-N-4-pyridinilcyclohexanecarboxamide dihydrochloride (Y-27632) and 1-(5-isoquinolinesulphonyl)homopiperazine (HA 1077), in comparison with myosin light chain kinase (MLCK) inhibitors, wortmannin and 1-(5-chloronaphthalenesulphonyl)homopiperazine (ML-9) and agents that affect protein kinase C (PKC) and non-receptor tyrosine kinase intracellular signalling. 2 In Ca(2+)-free/ethyleneglycol-bis-(beta-aminoethylether)N,N,N('),N(')-tetraacetic acid (EGTA) (1 mM) medium, noradrenaline evoked sustained contractions. Y-27632 and HA 1077 caused a concentration-dependent inhibition and complete relaxation (IC(50), 1.08 and 1.75 microM respectively). The Ca(2+)-free contraction was reduced by wortmannin (10 microM) or ML-9 (10 microM) but not by inhibitors of diacylglycerol metabolism, 3-[2-[4[bis(4-Fluoropheny)methylene]-1-piperidinyl]-2,3-dihydro-2-thioxi-4(H)-quinazolinone (R59949) (10 microm) or 1,6-bis(cyclohexyloximinocarbonylamino)hexane (RHC-80267) (10 microM) or by the phospholipase A(2) (PLA(2)) inhibitor, quinacrine (up to 100 microM) or tyrosine kinase inhibitor, genistein (30 microM). 3 In the presence of Ca(2+) (2.5 mM), noradrenaline (100 microM) evoked rhythmic activity and biphasic tonic contractions. Y-27632 (1-10 microM) or HA 1077 (1-10 microM) reduced the amplitude of rhythmic activity and tonic contractions. ML-9 (10 microM) attenuated the occurrence of rhythmic activity and modestly reduced the tonic contractions. ML-9 (10 microM) combined with Y-27632 (10 microM) significantly reduced the tonic contractions. ML-9 (30 microM) alone (or combined with Y-27632 10 microM) suppressed the rhythmic activity and substantially reduced (or abolished) the tonic contractions. 4 Contractions evoked by high [K(+)](o) (120 mM) or alpha,beta-methylene ATP (10 microM) were reduced significantly by Y-27632 (1-3 microM) indicating that the Rho kinase signalling pathway is activated by direct tissue depolarization or by stimulation of ligand-gated P(2X) purinoceptors. 5 Collectively, these results indicate that Ca(2+)-sensitization mediated by Rho kinase is involved in agonist- or depolarization-induced contraction of rat epididymal vas deferens. It is the major contractile mechanism underlying noradrenaline-induced Ca(2+)-free responses. It contributes to Ca(2+)-dependent rhythmic contractility and optimizes the development of full contractile tension triggered through calmodulin/MLCK activation by stimulated influx of Ca(2+).


Subject(s)
Muscle Contraction , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Vas Deferens/drug effects , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Amides/pharmacology , Animals , Azepines/pharmacology , Calcium/metabolism , Dose-Response Relationship, Drug , Egtazic Acid , In Vitro Techniques , Intracellular Signaling Peptides and Proteins , Male , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Myosin-Light-Chain Kinase/antagonists & inhibitors , Myosin-Light-Chain Kinase/metabolism , Norepinephrine/pharmacology , Potassium/metabolism , Protein Serine-Threonine Kinases/metabolism , Purinergic P2 Receptor Agonists , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X , Vas Deferens/physiology , rho-Associated Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...